ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
Eurofins Scientific SE

Eurofins Scientific SE (ERF)

46.94
0.62
( 1.34% )
업데이트: 20:15:00

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
46.94
매수가
46.93
매도가
46.95
거래량
189,394
46.36 일간 변동폭 47.21
39.47 52주 범위 62.10
market_cap
전일 종가
46.32
개장가
46.47
최근 거래 시간
28
@
46.94
마지막 거래 시간
20:13:45
재정 규모
-
VWAP
-
평균 볼륨(3m)
402,042
발행 주식
192,981,183
배당수익률
1.07%
주가수익률
29.24
주당순이익(EPS)
1.61
매출
6.54B
순이익
310.2M

Eurofins Scientific SE 정보

섹터
Testing Laboratories
산업
Testing Laboratories
웹사이트
본부
Grand Duche Du, Lux
설립됨
-
Eurofins Scientific SE is listed in the Testing Laboratories sector of the 유로넥스트 (Euronext) with ticker ERF. The last closing price for Eurofins Scientific was 46.32 €. Over the last year, Eurofins Scientific shares have traded in a share price range of 39.47 € to 62.10 €.

Eurofins Scientific currently has 192,981,183 shares in issue. The market capitalisation of Eurofins Scientific is 8.94 € billion. Eurofins Scientific has a price to earnings ratio (PE ratio) of 29.24.

ERF 최신 뉴스

CORRECTING and REPLACING: Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Regulatory News: This replaces the announcement made at 1:56 PM CEST on May 3 due to the following corrections: "Exercise of stock options and warrants" instead of "Exercise of stock options...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 30 April 2022

Regulatory News: Eurofins (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11...

Eurofins Core Business1 Delivers Strong Organic Revenue Growth in Q1 2022, in Line With Its Recently Upgraded Organic Growth2 Objective of 6.5% p.a.

Q1 2022 revenues of €1,760m, +9.1% vs. Q1 2021, despite a significant decrease in COVID related revenues Q1 2022 total revenue organic growth2 of +1.1% vs. Q1 2021, impacted by the reduction in...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 31 March 2022

Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal...

EUROFINS SCIENTIFIC SE : AVIS DE CONVOCATION DES ACTIONNAIRES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE ET A L’ASSEMBLEE GENERALE EXTRAORDINAIRE DE LA SOCIETE VALANT AVIS D’INFORMATION DES OBLIGATAIRES

Regulatory News: EUROFINS SCIENTIFIC SE (Paris:ERF): Les actionnaires de la Société, et uniquement avec voix consultative les porteurs de Deeply Subordinated Fixed to Floating Rate Bonds (ISIN...

Eurofins Genomics wird die Genotypisierung von bis zu 5 Millionen Teilnehmern an „Our Future Health“, dem bislang größten Gesundheitsforschungsprogramm des Vereinigten Königreichs, durchführen

Eurofins (Paris:ERF): Eurofins Genomics wird Our Future Health, das bislang größte Gesundheitsforschungsprogramm des Vereinigten Königreichs, unterstützen. Dazu wird Eurofins Genomics fünf...

Eurofins Genomics réalisera le génotypage de 5 millions de participants au programme Our Future Health, le plus grand du genre pour la recherche en santé jamais mis en place au Royaume-Uni.

Eurofins (Paris : ERF) : Eurofins Genomics est fier d'annoncer son soutien à Our Future Health, le plus grand programme de recherche en santé jamais mis en place au Royaume-Uni. Eurofins...

Eurofins Genomics Will Be Conducting Genotyping for up to 5 Million Participants of Our Future Health, UK’s Largest Ever Health Research Programme

Eurofins (Paris:ERF): Eurofins Genomics is proud to announce its support for Our Future Health, the UK’s largest ever health research programme. Eurofins Genomics will be genotyping five million...

Eurofins Scientific SE: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at 28 February 2022

Regulatory News: ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on...

Eurofins Significantly Exceeds Its Objectives in 2021 and Increases Its Objectives for 2022 and 2023

Regulatory News: Eurofins Scientific (Paris:ERF): Financial Highlights Eurofins delivered a very strong performance in FY 2021, exceeding all financial objectives: Record Revenues of €6,718m...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
11.182.5786713286745.7647.7545.3945757646.64246738DE
40.942.043478260874647.7544.5242765645.80472398DE
12-3.18-6.3447725458950.1258.2444.5240204250.21843457DE
26-10.16-17.793345008857.158.2439.4742785450.20752376DE
52-6.3-11.833208114253.2462.139.4737845352.96711528DE
156-68.14-59.2109836635115.08118.1239.4739221465.17165613DE
260-432.06-90.200417536547975439.4730978782.56425171DE

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
ALNEVNeovacs
0.0002 €
(100.00%)
2.8M
ALEUPEuroplasma
0.0547 €
(75.88%)
4.72M
ATOAtos SE
0.8108 €
(44.07%)
17.1M
ALGAUGaussin
0.0578 €
(37.62%)
1.73M
TMBSZTME Pharma NV
0.045 €
(32.35%)
160
BIDSGascogne DS
0.0008 €
(-63.64%)
56.51k
MLAAHAmatheon Agri Holding NV
0.011 €
(-45.00%)
1
MLMAZMazaro NV
2.16 €
(-28.00%)
500
EMGDSEuromedis DS
0.0006 €
(-25.00%)
10.64k
MLEFAEduformAction
0.402 €
(-17.96%)
3.95k
BCPBanco Comercial Portugues SA
0.4389 €
(-1.37%)
18.44M
ATOAtos SE
0.8108 €
(44.07%)
17.1M
ALDRVDrone Volt
0.0035 €
(0.00%)
16.42M
ALEUPEuroplasma
0.0547 €
(75.88%)
4.72M
LATLatecoere
0.0069 €
(-11.54%)
4.6M
Bull_Dolphin Bull_Dolphin 5 분 전
Enjoy your final waltz of the season with Mowtilda.
We are indeed in the midst of a beautiful stretch of weather.
I will take your advice and enjoy my oak tree and local critters.
Recently the Anhinga (We call it Auntie Hinga has been hanging around, also a pair of pileated Wood
Freddie bagholder Freddie bagholder 5 분 전
Scott first interview today or next week?
FNMA
ksquared ksquared 7 분 전
The two videos in the links should lighten your mood.
I can't get enough of them...
WKRP Turkey Drop
The beginning
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175440386
The end
https://investorshub.advfn.com/boards/read_m
jeunke22 jeunke22 7 분 전
No I haven’t. Sorry, Proto.
LWLG
stervc stervc 8 분 전
StocksGoneWild, with this superb MONI "dot to dot" DD...

StocksGoneWild, very well done in connecting the dots here with MONI once again. MONI is going to be teaching some people some very important lessons about patience being a virtue. All should read what you posted below as I beli
MONI
tw0122 tw0122 11 분 전
2.49 +'83%
CYCN
ksquared ksquared 12 분 전
I've long admired your wisdom, Bull.
The weather in your neck of the woods looks perfect for making music with your bride under the old oak tree.
P.S. Thanks for the warning. I haven't checked the papers yet.
P.P.S. Good day for the last mow job of the sea
Its_TradingG Its_TradingG 12 분 전
UncleBillyMoney AKA LongBullyStick is definitely a paid pumper, not delusional just manipulating investors who do not know better
IGPK
sab63090 sab63090 12 분 전
Investor
I thought it might speed up the process to approval, but I'm not sure of when Avanex has to apply!

Your reply was funny, but I did recommend his post...

Hope you enjoy Thanksgiving.....or at least have a great market holiday on Thursday and half day on
AVXL
NinjaForest32 NinjaForest32 13 분 전
Thank you DewDiligence !
ENTA
Jasbg Jasbg 13 분 전
You wonder what is the long term plan with Novo's latest takeover (BO) ?

https://www.seafoodsource.com/news/business-finance/novo-holdings-acquiring-salmon-genetics-firm-benchmark-genetics-in-deal-worth-up-to-usd-352-million
AMRN
cardmaster114 cardmaster114 15 분 전
Happy Thanksgiving to everyone and enjoy your time with your family. !!!!!!!!!!!!!!!!!!!!!!!!!!
DBMM
Saving Grace Saving Grace 16 분 전
"ASSESS" New High Grade Underground Scenario. Maintain Strong Balance Sheet!

An Assessor accounts for past performance. Note; "Deliverables"

By the time the UK is figuring out what's really going on, restoring connections. We'll be on to new, robust leach pad recovery
HYMC
floblu14 floblu14 16 분 전
Enanta Pharmaceuticals: Promising RSV Developments and Strong Immunology Pipeline Justify Buy Rating

Roy Buchanan, an analyst from JMP Securities, reiterated the Buy rating on Enanta Pharmaceuticals (ENTA – Research Report). The associated price target was lowered to $21.00.
ENTA
Bull_Dolphin Bull_Dolphin 17 분 전
Good morning kk. I need to follow your advice and get from the news. Too many items making my blood boil!
Konaploinks Konaploinks 18 분 전
Woops
IONQ
tw0122 tw0122 19 분 전
CYCN $2.26 + 70%
CYCN
ddls ddls 19 분 전
Let's see how low ActiPatch is on Amazon.😎

Currently ActiPitch 720 hour is #341 - KT-Recovery+Wave is #120

These numbers correlate to the best seller ranking. As we can see these products have no chance of making the inve
BIEL
ksquared ksquared 20 분 전
Morning, PC-Tamer Larry.
Glad you're up and running on all puter cylinders.
Have a good one.
BurgerKing82 BurgerKing82 21 분 전
Any potential here
NAFS
ksquared ksquared 24 분 전
Jeremy Slinker... The last name says it all.
Morning, Bull.
These gumpermint workers are going to get theirs.
Sheriffs Musk and Ramaswamy are riding into town.
Have a good one.
Jack Torrance Jack Torrance 24 분 전
The moat widens. I love that IonQ has the time and resources to move onto these types of innovations, because they are so far ahead in other ways. The other quantum companies are still working on their core designs while IonQ fleshes out all their quantum/hybrid accoutrement. This feels like an auto
IONQ
tw0122 tw0122 24 분 전
$1.10 +78%
HWH
Konaploinks Konaploinks 24 분 전
It’s beginning to look a lot like Christmas. Everywhere I onQ goes.
Keep your eye on IonQ
Mele Kalikimaka!
Haouli Makahiki Hou !
IONQ
prototype_101 prototype_101 27 분 전
Jeunke, just looking at the report on Fintel, I see on 11/14 that Goldman Sachs and Morgan Stanley both increased their holdings by more than 100%, do you have a listing of all the increased positions since the 9/30 report?

https://fintel.io/sob/us/lwlg

There are still
LWLG